Consun Pharmaceutical Group Ltd

C1P

Company Profile

  • Business description

    Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

  • Contact

    71, Dongpeng Avenue
    Eastern section
    Guangzhou Economic and Technological Development
    Guangzhou
    CHN

    T: +86 2082264529

    https://www.chinaconsun.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    3,073

Stocks News & Analysis

stocks

Westpac earnings: Tech overhaul is costly but not hurting lending and deposit growth

Our view after latest earnings report.
stocks

Future Focus: Are franking credits ‘free alpha’?

There’s always an opportunity cost.
stocks

Berkshire Hathaway earnings: Cash balances hit $358 billion on mostly solid results across the firm

We think Berkshire Hathaway stock is moderately undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,150.1023.90-0.26%
CAC 408,109.7911.28-0.14%
DAX 4024,132.41174.110.73%
Dow JONES (US)47,336.68226.19-0.48%
FTSE 1009,701.3715.88-0.16%
HKSE26,158.36251.710.97%
NASDAQ23,834.72109.770.46%
Nikkei 22552,294.31117.03-0.22%
NZX 50 Index13,643.8687.560.65%
S&P 5006,851.9711.770.17%
S&P/ASX 2008,863.6019.10-0.22%
SSE Composite Index3,976.5221.730.55%

Market Movers